Microbial Identification Market Report 2026

The microbial identification market size has grown rapidly in recent years. It will grow from $6.42 billion in 2025 to $7.41 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increasing infectious disease prevalence, reliance on culture-based diagnostics, expansion of food and water safety programs, rising regulatory compliance requirements, growing adoption of clinical microbiology testing.

The microbial identification market size is expected to see rapid growth in the next few years. It will grow to $12.09 billion in 2030 at a compound annual growth rate (CAGR) of 13%. The growth in the forecast period can be attributed to advancements in sequencing technologies, rising demand for rapid diagnostic methods, increasing automation in laboratory workflows, integration of digital platforms in microbial testing, expanding applications in pharmaceutical quality control. Major trends in the forecast period include genomic sequencing integration in microbial identification, cloud-based microbial data management, AI-assisted microorganism classification, automated identification platforms in industrial testing, iot-enabled monitoring in microbial detection.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the microbial identification market in the coming years. Infectious diseases are caused by pathogenic microorganisms, including bacteria, viruses, fungi, parasites, or prions. These diseases arise due to factors such as climate change, environmental disruption, antimicrobial resistance, weakened immune systems, and ecological disturbances. Microbial identification plays a critical role in ensuring accurate diagnosis, enabling targeted treatment, supporting disease surveillance, controlling outbreaks, and promoting antimicrobial stewardship in the management of infectious diseases. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Consequently, the growing prevalence of infectious diseases fuels the demand for microbial identification.

Major companies in the microbial identification market are concentrating on developing advanced solutions, such as automated sample preparation platforms, to enhance the speed and accuracy of microbial detection. Sample preparation platforms are technological systems that process and prepare biological or clinical samples for analysis, improving efficiency and diagnostic accuracy. For example, in September 2024, Accelerate Diagnostics Inc., a US-based in vitro diagnostics company, received FDA clearance for the Accelerate Arc system, an advanced automated solution designed to quickly identify microbes directly from positive blood culture samples. By automating the sample preparation process through integration with the Bruker MALDI Biotyper CA System, the solution substantially shortens the time to results, allowing clinicians to start targeted antibiotic therapy sooner, improve patient outcomes, and lower the risk of antimicrobial resistance. FDA-cleared, the Accelerate Arc system is designed to boost operational efficiency in clinical laboratories.

In January 2023, Biolog Inc., a US-based cellular analysis company, acquired MIDI Inc. for an undisclosed sum. Through this acquisition, Biolog Inc. strengthens its microbial identification and phenotypic profiling capabilities, expanding its portfolio to deliver comprehensive microbial analysis solutions. MIDI Inc. is a US-based microbial identification firm specializing in microbial identification and analysis.

Major companies operating in the microbial identification market are Merck & Co Inc, ThermoFisher Scientific Inc, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Avantor Inc, Eurofins Scientific Corporation, Beckman Coulter Inc, VWR International LLC, Charles River Laboratories International Inc, PerkinElmer Inc, Wickham Micro Limited, Bruker Corporation, bioMérieux SA, Biolog Inc, Liofilchem Srl, Shimadzu Corporation, Scenker Biological Technology Co Ltd, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN NV, Roche Diagnostics, Illumina Inc, Oxford Nanopore Technologies.

North America was the largest region in the microbial identification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbial identification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial identification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on laboratory instruments, sequencing platforms, and diagnostic reagents have raised the operational costs for microbial identification labs, especially in regions dependent on imports such as Europe and Asia-Pacific. These tariffs disrupt supply chains for PCR reagents, consumables, and culture media, affecting testing capacity and turnaround times. However, they have encouraged local manufacturing of reagents and equipment, stimulating regional innovation and reducing long-term dependency on imported technologies.

The microbial identification market research report is one of a series of new reports that provides microbial identification market statistics, including microbial identification industry global market size, regional shares, competitors with a microbial identification market share, detailed microbial identification market segments, market trends and opportunities, and any further data you may need to thrive in the microbial identification industry. This microbial identification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microbial identification is the process of detecting, classifying, and characterizing microorganisms - including bacteria, fungi, viruses, and protozoa - based on their phenotypic and genotypic traits. Combining these approaches enables precise, rapid, and thorough identification of microorganisms, which is essential for diagnosing, treating, and monitoring infections.

The primary product types and services for microbial identification include instruments, consumables, and services. Microbial identification instruments are devices and tools designed to detect, classify, and identify microorganisms such as bacteria, viruses, fungi, and parasites. Various techniques, including phenotypic, proteotypic, and genotypic methods, are employed across multiple applications, such as diagnostics, environmental testing, food and beverage analysis, and pharmaceutical testing. These services cater to a range of end users, including the pharmaceutical and biotechnology sector, food and beverage industry, water and environmental agencies, independent research laboratories, diagnostic laboratories, hospitals, and others.

The microbial identification market consists of revenues earned by entities by providing services such as custom and specialized testing, clinical diagnostics, and microbial source tracking. Only goods and services traded between entities or sold to end consumers are included. The microbial identification market also consists of sales of microarray systems, genomic instruments, and culture testing instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.